Feist-Weiller Cancer Center (FWCC) was designated a Center of Excellence in Cancer Research, Treatment and Education in 1993. At Feist-Weiller Cancer Center, oncologists, hematologists, surgeons, radiologists, therapists, and basic science researchers collaborate to offer preeminent cancer research, cancer prevention programs and excellent treatment to cancer patients.
Four scientific programs facilitate comprehensive and unique patient care at Feist-Weiller Cancer Center: the Program in Translational Research, focus groups in Cancer Cell Biology, the Program in Tumor Virology, and the Innovative North Louisiana Experimental Therapeutics (INLET) Program. FWCC also has a partnership with St. Jude Children’s Research Hospital and the FWCC’s outpatient facility includes a St. Jude Affiliate Clinic where children are treated according to detailed St. Jude protocols. Among the signature strengths of Feist-Weiller Cancer Center is translational cancer research in which physicians and scientists take clinical problems from the bedside to the research laboratory where solutions are generated that come back to the bedside. This type of research allows the scientific discoveries to more rapidly become practical applications that can be used in assessment and treatment of cancer patients. Feist-Weiller Cancer Center leads enrollment for numerous clinical trials in the Southwest Oncology Group NCI Community Oncology Research Program (NCORP).
Dr. Sarah Thayer, MD, PhD, FACS
Director of Feist-Weiller Cancer Center
Medical oncologists and hematologists at Feist-Weiller Cancer Center are board certified in internal medicine, then specially trained and certified in medical oncology (cancer medicine), hematology (blood disorders) or both. Specialists in Surgical Oncology, ENT Oncology, Radiation Oncology, GYN Oncology, Urologic Oncology, Neuro Oncology and Orthopaedic Oncology join forces with adult and pediatric oncologists and hematologists to develop the most appropriate and personalized treatment plan for each patient.
Among the signature strengths of Feist-Weiller Cancer Center is translational cancer research in which physicians and scientists take clinical problems from the bedside to the research laboratory where solutions are generated that come back to the bedside. This type of research allows the scientific discoveries to more rapidly become practical applications that can be used in assessment and treatment of cancer patients.
Patient care at Feist-Weiller Cancer Center is comprehensive and unique. Through LSU Health Shreveport's partnership with St. Jude Children's Research Hospital, the outpatient facility includes a St. Jude Affiliate Clinic in which children are treated according to detailed St. Jude protocols. In addition, adult patients have opportunities to participate in clinical trials with the newest treatments to combat cancer. Feist-Weiller Cancer Center is humbled by the number of patients who, by their own choice, take advantage of exploring novel therapeutic interventions. Feist-Weiller Cancer Center leads enrollment for numerous clinical trials in the Southwest Oncology Group.
MISSION AND VALUES
Feist-Weiller Cancer Center engages in multidisciplinary, translational cancer research, provides patients cutting-edge treatment with access to national cancer clinical trials, and educates both physicians and the community about the prevention, treatment, and the science of cancer.
The Feist-Weiller Cancer Center team is committed to bringing life-saving discoveries about cancer to all of Louisiana and beyond. Collaboration between cancer researchers and treating physicians fosters a more comprehensive understanding of cancer. Feist-Weiller Cancer Center faculty:
- conduct laboratory research and clinical research to discover better methods of preventing and treating cancer
- provide adult and pediatric patients with state-of-the-art cancer care, regardless of their ability to pay
- educate and train Hematology/Oncology Fellows, community physicians, and local residents about the most modern cancer treatments so all patients will receive the best possible cancer care
- supply Louisiana communities with cancer screenings and education materials for prevention through Partners in Wellness, a unique community cancer screening program
Dr. Sarah Thayer has been appointed by Governor John Bel Edwards to the Louisiana Cancer and Lung Trust Fund Board. The Louisiana Cancer and Lung Trust Fund Board serves to determine policy for the Louisiana Tumor Registry and distribute state funds for cancer research.
Ellen Friday, PhD, Clinical Assistant Professor and Researcher at LSUHS, is among the first 100 people globally to pass the QBRS exam and receive this credential, a distinction among biorepository science professionals.
The TMIST clinical trial is studying current mammography methods to change the "one size fits all" approach to breast cancer screening.
Dr. Arrigo DeBenedetti receives Spring 2021 Feist Weiller Cancer Center (FWCC) Bridging Award grant in the amount of $100,000.